胶原杂交肽放射性示踪剂用于肺纤维化胶原周转的分子成像
研究合成并评估了99mTc标记的胶原杂交肽示踪剂99mTc-(HE)3-(GPO)9,在博来霉素诱导的小鼠肺纤维化模型中行SPECT/CT成像。诱导后3周,博来霉素处理小鼠肺部特异性摄取高于对照组(P < 0.01),也高于纤维化已消退的8-10周组(P < 0.05);SPECT/CT定量与γ井计数显著相关(Pearson R = 0.83,P < 0.001),且示踪剂摄取与组织纤维化指标显著相关。结论认为该示踪剂可实现肺纤维化胶原周转的SPECT成像。
要点
- 99mTc-(HE)3-(GPO)9的比活度为70.3 ± 14.8 GBq/µmol,在血液中至少稳定2小时并快速清除。
- 博来霉素诱导后3周小鼠肺部特异性摄取高于对照组(P < 0.01)和8-10周纤维化消退组(P < 0.05)。
- SPECT/CT定量与γ井计数显著相关(Pearson R = 0.83,P < 0.001),示踪剂摄取与组织纤维化指标显著相关。
核心结论
- 99mTc-(HE)3-(GPO)9可实现肺纤维化中胶原周转的SPECT成像。
- 该方法扩展了现有纤维化诊断工具的范围,并可能通过监测抗纤维化治疗效果来改善患者管理。
研究设计与样本
- 合成多组氨酸或聚组氨酸-谷氨酸[(HE)3]肽通过三甘氨酸连接子连接N端含9个甘氨酸-脯氨酸-羟脯氨酸重复[(GPO)9]的靶向部分,经99mTc-三羰基放射性标记。
- 用高效液相色谱和γ井计数评估标记产物的纯度和稳定性,并在小鼠中比较生物分布。
- 8-10周龄小鼠肺部暴露于博来霉素(或生理盐水作为对照)诱导肺纤维化,诱导后3周注射99mTc-(HE)3-(GPO)9后1小时行SPECT/CT成像,随后采集组织经γ井计数评估生物分布并评估肺组织学。
- 使用乱序同源物评估示踪剂摄取的特异性;一组动物在诱导后3周和8-10周进行系列成像。
主要发现
- 最终放射性标记产物的比活度为70.3 ± 14.8 GBq/µmol。
- 放射性标记示踪剂在血液中至少稳定2小时,并显示快速血液清除。
- 99mTc-(HE)3-(GPO)9在生物分布研究中显示较低的肝脏摄取,被选用于体内成像研究。
- 博来霉素处理小鼠诱导后3周SPECT/CT成像显示肺部特异性99mTc-(HE)3-(GPO)9摄取高于对照组小鼠(P < 0.01),也高于纤维化已消退的博来霉素处理小鼠8-10周时(P < 0.05)。
- SPECT/CT定量的肺部摄取与γ井计数显著相关(Pearson R = 0.83,P < 0.001),示踪剂摄取与组织纤维化指标显著相关。
关键数值与推荐
- 最终放射性标记产物比活度为70.3 ± 14.8 GBq/µmol。
- 博来霉素处理小鼠诱导后3周肺部特异性摄取高于对照组(P < 0.01)。
- 博来霉素处理小鼠诱导后3周肺部特异性摄取高于8-10周纤维化消退时(P < 0.05)。
- SPECT/CT定量与γ井计数相关(Pearson R = 0.83,P < 0.001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Pulmonary fibrosis is a characteristic feature of interstitial lung disease. Current clinical diagnostic methods provide a snapshot of the lung structure without information on disease activity. Collagen hybridizing peptides offer the opportunity to detect collagen remodeling through their hybridization with denatured collagen. Here, we sought to develop a 99mTc-labeled collagen hybridizing tracer to track denatured collagen in vivo and validate it in a murine model of pulmonary fibrosis. Methods: Imaging agents consisting of a polyhistidine or a poly-histidine-glutamic acid [(HE)3] peptide connected to an N-terminal targeting moiety with 9 glycine-proline-hydroxyproline repeats [(GPO)9] through a 3-glycine linker were synthesized. After radiolabeling with 99mTc-tricarbonyl, the labeled products' purity and stability were evaluated by high-performance liquid chromatography and γ-well counting, and their biodistributions were compared in mice. To induce pulmonary fibrosis, the lungs of 8- to 10-wk-old mice were exposed to bleomycin (or saline as control). At 3 wk after induction, SPECT/CT imaging with 99mTc-(HE)3-(GPO)9 was performed 1 h after injection and was followed by tissue collection to assess 99mTc-(HE)3-(GPO)9 biodistribution by γ-well counting and to evaluate lung histology. The specificity of the tracer uptake was assessed using a scrambled homolog. A group of animals underwent serial imaging 3 and 8-10 wk after induction. Results: The specific activity of the final radiolabeled product was 70.3 ± 14.8 GBq/µmol. Radiolabeled tracers were stable in blood for at least 2 h and showed rapid blood clearance. 99mTc-(HE)3-(GPO)9 showed lower liver uptake in biodistribution studies and was selected for in vivo imaging studies. SPECT/CT imaging of bleomycin-treated mice 3 wk after induction showed higher specific 99mTc-(HE)3-(GPO)9 lung uptake than that of control mice (P < 0.01) and that of bleomycin-treated mice 8-10 wk after induction, when fibrosis was resolved (P < 0.05). There was a significant correlation between lung uptake quantified by SPECT/CT and γ-well counting (Pearson R = 0.83, P < 0.001) and significant correlations between tracer uptake and indices of tissue fibrosis. Conclusion: 99mTc-(HE)3-(GPO)9 enables SPECT imaging of collagen turnover in pulmonary fibrosis. This approach expands the scope of existing diagnostic tools in fibrosis and can lead to better patient management by monitoring the effect of antifibrotic therapies.
引用
- Ahmad AA, Ghim M, Kukreja G, et al. Collagen Hybridizing Peptide-Based Radiotracers for Molecular Imaging of Collagen Turnover in Pulmonary Fibrosis. J Nucl Med. 2025. PMID: 39915119. doi:10.2967/jnumed.124.268832
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。